Does LORAZEPAM Cause Hepatic cytolysis? 50 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Hepatic cytolysis have been filed in association with LORAZEPAM (Lorazepam). This represents 0.2% of all adverse event reports for LORAZEPAM.
50
Reports of Hepatic cytolysis with LORAZEPAM
0.2%
of all LORAZEPAM reports
0
Deaths
23
Hospitalizations
How Dangerous Is Hepatic cytolysis From LORAZEPAM?
Of the 50 reports, 23 (46.0%) required hospitalization, and 6 (12.0%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which LORAZEPAM Alternatives Have Lower Hepatic cytolysis Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN